Increased circulating angiotensin-(1-7) protects white adipose tissue against development of a proinflammatory state stimulated by a high-fat diet

Regulatory Peptides

Volumn 178, Issue 1-3, 2012, Pages 64-70

  Santos, Sérgio Henrique S ^a,b   Fernandes, Luciana Rodrigues ^a   Pereira, Camila Santos ^b   Guimarães, André L Senna ^b   de Paula, Alfredo M B ^b   Campagnole Santos, Maria José ^a   Alvarez Leite, Jacqueline Isaura ^a   Bader, Michael ^c   Santos, Robson Augusto S ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b UNIMONTES   (Brazil)

^c MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

Angiotensin (1 7); Hyperlipidic diet; Inflammation; Metabolism; Obesity

Indexed keywords

ADIPONECTIN; ANGIOTENSIN[1-7]; CYCLOOXYGENASE 2; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 1BETA; LEPTIN;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY FAT DISTRIBUTION; BODY WEIGHT; CONTROLLED STUDY; FOOD INTAKE; GLUCOSE TOLERANCE; IMMUNOHISTOCHEMISTRY; INSULIN SENSITIVITY; LIPID BLOOD LEVEL; MALE; METABOLIC STRESS; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; REAL TIME POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT; TRANSGENIC RAT; WESTERN BLOTTING;

ADIPOKINES; ADIPOSITY; ANGIOTENSIN I; ANIMALS; BLOOD GLUCOSE; CHOLESTEROL, HDL; DIET, HIGH-FAT; EPIDIDYMIS; INFLAMMATION; INFLAMMATION MEDIATORS; INTERLEUKIN-1BETA; INTRA-ABDOMINAL FAT; MALE; OBESITY; OXIDATIVE STRESS; PEPTIDE FRAGMENTS; RATS; RATS, SPRAGUE-DAWLEY; RATS, TRANSGENIC; TUMOR NECROSIS FACTOR-ALPHA;

RATTUS;

EID: 84865366392     PISSN: 01670115     EISSN: 18731686     Source Type: Journal    
DOI: 10.1016/j.regpep.2012.06.009     Document Type: Article

References (48)

1. Jackson A.W., Lee D.C., Sui X., Morrow J.R., Church T.S., Maslow A.L., Blair S.N. Muscular strength is inversely related to prevalence and incidence of obesity in adult men. Obesity (Silver Spring) 2010, 18:1988-1995.
2. de Ferranti S., Mozaffarian D. The perfect storm: obesity, adipocyte dysfunction, and metabolic consequences. Clin Chem 2008, 54:945-955.
3. Bray G.A., Popkin B.M. Dietary fat intake does affect obesity!. Am J Clin Nutr 1998, 68:1157-1173.
4. Hill J.O., Melanson E.L., Wyatt H.T. Dietary fat intake and regulation of energy balance: implications for obesity. J Nutr 2000, 130:284S-288S.
5. West D.B., York B. Dietary fat, genetic predisposition, and obesity: lessons from animal models. Am J Clin Nutr 1998, 67:505S-512S.
6. Fantuzzi G. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 2005, 115:911-919. Quiz 20.
7. Greenberg A.S., Obin M.S. Obesity and the role of adipose tissue in inflammation and metabolism. Am J Clin Nutr 2006, 83:461S-465S.
8. Trayhurn P., Wood I.S. Signalling role of adipose tissue: adipokines and inflammation in obesity. Biochem Soc Trans 2005, 33:1078-1081.
9. Yudkin J.S., Stehouwer C.D., Emeis J.J., Coppack S.W. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?. Arterioscler Thromb Vasc Biol 1999, 19:972-978.
10. Festa A., D'Agostino R., Williams K., Karter A.J., Mayer-Davis E.J., Tracy R.P., Haffner S.M. The relation of body fat mass and distribution to markers of chronic inflammation. Int J Obes Relat Metab Disord 2001, 25:1407-1415.
11. Engstrom G., Hedblad B., Stavenow L., Lind P., Janzon L., Lindgarde F. Inflammation-sensitive plasma proteins are associated with future weight gain. Diabetes 2003, 52:2097-2101.
12. Hsieh P.S., Jin J.S., Chiang C.F., Chan P.C., Chen C.H., Shih K.C. COX-2-mediated inflammation in fat is crucial for obesity-linked insulin resistance and fatty liver. Obesity (Silver Spring) 2009, 17:1150-1157.
13. Hsieh P.S., Lu K.C., Chiang C.F., Chen C.H. Suppressive effect of COX2 inhibitor on the progression of adipose inflammation in high-fat-induced obese rats. Eur J Clin Invest 2010, 40:164-171.
14. Ruiz-Ortega M., Lorenzo O., Suzuki Y., Ruperez M., Egido J. Proinflammatory actions of angiotensins. Curr Opin Nephrol Hypertens 2001, 10:321-329.
15. Owen C.A., Campbell E.J. Angiotensin II generation at the cell surface of activated neutrophils: novel cathepsin G-mediated catalytic activity that is resistant to inhibition. J Immunol 1998, 160:1436-1443.
16. da Silveira K.D., Coelho F.M., Vieira A.T., Sachs D., Barroso L.C., Costa V.V., Bretas T.L., Bader M., de Sousa L.P., da Silva T.A., dos Santos R.A., Simoes e Silva A.C., Teixeira M.M. Anti-inflammatory effects of the activation of the angiotensin-(1-7) receptor, MAS, in experimental models of arthritis. J Immunol 2010, 185:5569-5576.
17. Walsh D.A., Suzuki T., Knock G.A., Blake D.R., Polak J.M., Wharton J. AT1 receptor characteristics of angiotensin analogue binding in human synovium. Br J Pharmacol 1994, 112:435-442.
18. Kane J.P., Hardman D.A., Paulus H.E. Heterogeneity of apolipoprotein B: isolation of a new species from human chylomicrons. Proc Natl Acad Sci U S A 1980, 77:2465-2469.
19. Boustany C.M., Bharadwaj K., Daugherty A., Brown D.R., Randall D.C., Cassis L.A. Activation of the systemic and adipose renin-angiotensin system in rats with diet-induced obesity and hypertension. Am J Physiol Regul Integr Comp Physiol 2004, 287:R943-R949.
20. Cassis L.A., Police S.B., Yiannikouris F., Thatcher S.E. Local adipose tissue renin-angiotensin system. Curr Hypertens Rep 2008, 10:93-98.
21. Poirier P. Adiposity and cardiovascular disease: are we using the right definition of obesity?. Eur Heart J 2007, 28:2047-2048.
22. Santos S.H., Fernandes L.R., Mario E.G., Ferreira A.V., Porto L.C., Alvarez-Leite J.I., Botion L.M., Bader M., Alenina N., Santos R.A. Mas deficiency in FVB/N mice produces marked changes in lipid and glycemic metabolism. Diabetes 2008, 57:340-347.
23. Brosnihan K.B., Li P., Ferrario C.M. Angiotensin-(1-7) dilates canine coronary arteries through kinins and nitric oxide. Hypertension 1996, 27:523-528.
24. Giani J.F., Mayer M.A., Munoz M.C., Silberman E.A., Hocht C., Taira C.A., Gironacci M.M., Turyn D., Dominici F.P. Chronic infusion of angiotensin-(1-7) improves insulin resistance and hypertension induced by a high-fructose diet in rats. Am J Physiol Endocrinol Metab 2009, 296:E262-E271.
25. Santos S.H., Braga J.F., Mario E.G., Porto L.C., Rodrigues-Machado Mda G., Murari A., Botion L.M., Alenina N., Bader M., Santos R.A. Improved lipid and glucose metabolism in transgenic rats with increased circulating angiotensin-(1-7). Arterioscler Thromb Vasc Biol 2010, 30:953-961.
26. Santos R.A., Ferreira A.J., Nadu A.P., Braga A.N., de Almeida A.P., Campagnole-Santos M.J., Baltatu O., Iliescu R., Reudelhuber T.L., Bader M. Expression of an angiotensin-(1-7)-producing fusion protein produces cardioprotective effects in rats. Physiol Genomics 2004, 17:292-299.
27. Akagiri S., Naito Y., Ichikawa H., Mizushima K., Takagi T., Handa O., Kokura S., Yoshikawa T. A Mouse model of metabolic syndrome; increase in visceral adipose tissue precedes the development of fatty liver and insulin resistance in high-fat diet-fed male KK/Ta mice. J Clin Biochem Nutr 2008, 42:150-157.
28. Teixeira L.G., Leonel A.J., Aguilar E.C., Batista N.V., Alves A.C., Coimbra C.C., Ferreira A.V., de Faria A.M., Cara D.C., Alvarez Leite J.I. The combination of high-fat diet-induced obesity and chronic ulcerative colitis reciprocally exacerbates adipose tissue and colon inflammation. Lipids Health Dis 2011, 10:204.
29. Brown M.S., Goldstein J.L. A receptor-mediated pathway for cholesterol homeostasis. Science 1986, 232:34-47.
30. Jayasooriya A.P., Mathai M.L., Walker L.L., Begg D.P., Denton D.A., Cameron-Smith D., Egan G.F., McKinley M.J., Rodger P.D., Sinclair A.J., Wark J.D., Weisinger H.S., Jois M., Weisinger R.S. Mice lacking angiotensin-converting enzyme have increased energy expenditure, with reduced fat mass and improved glucose clearance. Proc Natl Acad Sci U S A 2008, 105:6531-6536.
31. Mario E.G., Santos S.H., Ferreira A.V., Bader M., Santos R.A., Botion L.M. Angiotensin-(1-7) Mas-receptor deficiency decreases peroxisome proliferator-activated receptor gamma expression in adipocytes. Peptides 2012, 33:174-177.
32. Liang C., Oest M.E., Jones J.C., Prater M.R. Gestational high saturated fat diet alters C57BL/6 mouse perinatal skeletal formation. Birth Defects Res B Dev Reprod Toxicol 2009, 86:362-369.
33. Kupai K., Csonka C., Fekete V., Odendaal L., van Rooyen J., Marais de W., Csont T., Ferdinandy P. Cholesterol diet-induced hyperlipidemia impairs the cardioprotective effect of postconditioning: role of peroxynitrite. Am J Physiol Heart Circ Physiol 2009, 297:H1729-H1735.
34. Holloway C.J., Cochlin L.E., Emmanuel Y., Murray A., Codreanu I., Edwards L.M., Szmigielski C., Tyler D.J., Knight N.S., Saxby B.K., Lambert B., Thompson C., Neubauer S., Clarke K. A high-fat diet impairs cardiac high-energy phosphate metabolism and cognitive function in healthy human subjects. Am J Clin Nutr 2011, 93:748-755.
35. Gustafson B., Hammarstedt A., Andersson C.X., Smith U. Inflamed adipose tissue: a culprit underlying the metabolic syndrome and atherosclerosis. Arterioscler Thromb Vasc Biol 2007, 27:2276-2283.
36. Alexandraki K., Piperi C., Kalofoutis C., Singh J., Alaveras A., Kalofoutis A. Inflammatory process in type 2 diabetes: the role of cytokines. Ann N Y Acad Sci 2006, 1084:89-117.
37. Yudkin J.S., Kumari M., Humphries S.E., Mohamed-Ali V. Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?. Atherosclerosis 2000, 148:209-214.
38. Lagathu C., Yvan-Charvet L., Bastard J.P., Maachi M., Quignard-Boulange A., Capeau J., Caron M. Long-term treatment with interleukin-1beta induces insulin resistance in murine and human adipocytes. Diabetologia 2006, 49:2162-2173.
39. Wewers M.D. IL-1beta: an endosomal exit. Proc Natl Acad Sci U S A 2004, 101:10241-10242.
40. Lagathu C., Bastard J.P., Auclair M., Maachi M., Capeau J., Caron M. Chronic interleukin-6 (IL-6) treatment increased IL-6 secretion and induced insulin resistance in adipocyte: prevention by rosiglitazone. Biochem Biophys Res Commun 2003, 311:372-379.
41. Zhang H.H., Kumar S., Barnett A.H., Eggo M.C. Dexamethasone inhibits tumor necrosis factor-alpha-induced apoptosis and interleukin-1 beta release in human subcutaneous adipocytes and preadipocytes. J Clin Endocrinol Metab 2001, 86:2817-2825.
42. Bunout D., Munoz C., Lopez M., de la Maza M.P., Schlesinger L., Hirsch S., Pettermann M. Interleukin 1 and tumor necrosis factor in obese alcoholics compared with normal-weight patients. Am J Clin Nutr 1996, 63:373-376.
43. Um J.Y., Chung H.S., Song M.Y., Shin H.D., Kim H.M. Association of interleukin-1beta gene polymorphism with body mass index in women. Clin Chem 2004, 50:647-650.
44. Fain J.N., Madan A.K., Hiler M.L., Cheema P., Bahouth S.W. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology 2004, 145:2273-2282.
45. Juge-Aubry C.E., Somm E., Chicheportiche R., Burger D., Pernin A., Cuenod-Pittet B., Quinodoz P., Giusti V., Dayer J.M., Meier C.A. Regulatory effects of interleukin (IL)-1, interferon-beta, and IL-4 on the production of IL-1 receptor antagonist by human adipose tissue. J Clin Endocrinol Metab 2004, 89:2652-2658.
46. Somm E., Cettour-Rose P., Asensio C., Charollais A., Klein M., Theander-Carrillo C., Juge-Aubry C.E., Dayer J.M., Nicklin M.J., Meda P., Rohner-Jeanrenaud F., Meier C.A. Interleukin-1 receptor antagonist is upregulated during diet-induced obesity and regulates insulin sensitivity in rodents. Diabetologia 2006, 49:387-393.
47. Souza L.L., Costa-Neto C.M. Angiotensin-(1-7) decreases LPS-induced inflammatory response in macrophages. J Cell Physiol 2011, 227(5):2117-2122.
48. McGillicuddy F.C., Harford K.A., Reynolds C.M., Oliver E., Claessens M., Mills K.H., Roche H.M. Lack of interleukin-1 receptor I (IL-1RI) protects mice from high-fat diet-induced adipose tissue inflammation coincident with improved glucose homeostasis. Diabetes 2011, 60:1688-1698.